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ABSTRACT 
 
Objective: To determine the efficacy and dermal tolerance of a novel alcohol-based skin 
antiseptic (ABSA) in horses. 
Study Design: Experimental study. 
Animal Population: Systemically healthy horses (n=25) with no history or clinical signs 
of skin disease. 
Methods: Four clipped sites on the abdomen were randomly assigned to a skin 
preparation protocol: saline (NC), chlorhexidine gluconate followed by isopropyl alcohol 
(PC), saline followed by the ABSA (ABSA A), or a commercially available horse 
shampoo followed by the ABSA (ABSA B). Microbiology swabs were taken from each 
site and cultured on MacConkey and mannitol salt agar plates. Colony forming units were 
counted 18-24 hours later. All sites were scored for signs of skin reaction before, 
immediately after, 1 hour after, and 24 hours after skin preparation. 
Results: The PC, ABSA A and ABSA B methods were effective at reducing skin microbial 
burden when compared to the NC method (P <0.001) and there was no difference 
between antiseptic products. Both the ABSA A (P <0.001) and ABSA B (P <0.001) 
methods took less time than the PC method but there was no difference between the 
ABSA methods (P = 0.108). Skin reactions were most abundant at 24 hours after skin 
preparation (30.5%), but there was no significant association with antiseptic used and no 
horses required veterinary treatment. 
Conclusions: The alcohol-based skin antiseptic used in this study is an efficacious, fast-
acting and well tolerated antiseptic for achieving skin antisepsis in horses. Further 
validation is required to determine its safety and effectiveness in clinical cases.  
INTRODUCTION 
 
Aseptic preparation of the patient’s skin is an essential step in the prevention of surgical 
site infections (SSI).1-3 Many studies have attempted to establish the optimum pre-
operative skin preparation protocol for the patient, both human2 and veterinary,1,3-10 as 
well as for the surgeon.11-13 The variables most commonly investigated are total time 
required and product used. 
 
In an ideal situation, the total time required to achieve a sterile surgical field is as short as 
possible. This is especially important in equine patients undergoing general anaesthesia 
as perioperative mortality increases with anaesthetic duration.14 Protocols as short as 4 
minutes for the patient,1 and 2 minutes for the surgeon,13 have been proven to be effective 
using 4% chlorhexidine gluconate (CHXG). Similarly, Zubrod et al10 showed that three 
30 second scrubs with povidine-iodine (PI) was as effective as a 10 minute scrub or the 
application of a commercial one-step PI solution in horses. 
 
Recently, the use of alcohol-based skin antiseptics (ABSAs) has gained interest11-12,15; 
studies have shown that they are as effective as and faster than traditional antiseptic 
products in preparing the veterinary surgeon.12 However, no studies have looked at the 
efficacy of such products on the veterinary patient where they may also be effective and 
require a shorter preparation time.  
 
Another consideration for the use of antiseptics on the patient and surgeon is dermal 
tolerance. Aseptic skin preparation is not always innocuous, with some patients1-3 and 
surgeons13 suffering from skin reactions to certain products. Osuna et al7-8 established 
that CHXG is better tolerated than PI in the pre-operative preparation of dogs but no 
objective data exists regarding the tolerance of either traditional antiseptics or ABSAs in 
horses.  
 
The alcohol-based products previously investigated11-12 are designed for pre-operative 
preparation of the surgeon and are not intended for use on the patient.16-17 The ABSA 
used in this study (Cutasept F; BODE Chemie GmbH, Hamburg, Germany) is 
specifically designed for pre-operative skin preparation in humans patients and is 
reported to be both efficacious and well tolerated.18 It is a non-coloured skin antiseptic 
containing propan-2-ol (72%) and benzalkonium chloride (<1%) with a recommended 
contact time of 2 minutes for skin that is rich in sebaceous glands,19 as is the case with 
equine skin. 
 
The aim of this study was to determine the efficacy of an ABSA in reducing the skin 
microbial burden in horses compared to another commonly used skin antiseptic (CHXG) 
and a control (saline), and to report on the dermal tolerance of these methods. We 
hypothesised that the ABSA would be as effective as CHXG, faster than a standard 
CHXG skin preparation method, and well tolerated by equine patients.   
MATERIALS AND METHODS 
 
The study was approved by the University of Bristol’s Animal Welfare and Ethical 
Review Body. Written informed consent was obtained from the owner of each horse prior 
to participating in the study. 
 
Skin Preparation 
Systemically healthy horses with no history or clinical signs of skin disease were 
included in the study. The mid-to-ventral abdomen was brushed five times with a clean, 
soft brush in the direction of hair growth to remove any gross debris. Four sites 
measuring 5 x 5 centimetres were then clipped using a number 40 clipper blade, 
approximately 5 centimetres apart from cranial to caudal, on the mid-to-ventral abdomen 
(Figure 1) and numbered consecutively from 1 (closest to elbow) to 4 (closest to flank). 
Each site was randomly assigned (www.randomizer.org) to one of 4 skin preparation 
methods and all skin preparations were conducted by a single operator wearing sterile 
gloves. The time required to obtain grossly clean swabs during the NC, ABSA A and 
ABSA B methods was noted. 
 
• Negative control [NC] – the site was scrubbed in a circular motion, focused around 
the central point with gauze swabs soaked in sterile saline until the used swabs 
appeared grossly clean after use. The site was then dried with 2 dry sterile gauze 
swabs. 
• Positive control [PC] – the site was scrubbed in a circular motion, focused around 
the central point with gauze swabs soaked in 4% chlorhexidine gluconate (Vetasept 
Chlorhexidine Surgical Scrub; Animalcare Ltd, York, United Kingdom). Each swab 
was used for 30 seconds and 10 swabs were used, giving a total scrub time of 5 
minutes. Excess lather was then removed from the site using 2 sterile gauze swabs 
soaked in 70% isopropyl alcohol and the site was allowed to dry by evaporation. 
• ABSA A – the site was scrubbed in a circular motion, focused around the central 
point with gauze swabs soaked in sterile saline until the used swabs appeared 
grossly clean after use. The site was then dried with 2 dry sterile gauze swabs. 
Sterile gauze swabs soaked in the ABSA (Cutasept F) were applied to the site, 
ensuring continual wetting for 2 minutes, and the site was allowed to dry by 
evaporation. 
• ABSA B – the site was scrubbed in a circular motion, focused around the central 
point with gauze swabs soaked in a commercially available horse shampoo (Gallop 
Conditioning Shampoo; Carr & Day & Martin Ltd, Lytham, United Kingdom) until 
the used swabs appeared grossly clean after use. Excess lather was then removed 
from the site using 2 swabs soaked in tap water and the site was dried with 2 dry 
gauze swabs. Gauze swabs soaked in the ABSA (Cutasept F) were applied to the 




Immediately following the completion of skin preparation at each site, a sterile 
microbiological swab was placed into 1ml of liquid Amies preservation medium (ESwab; 
Copan Diagnostics Inc, Murrieta, California) within a sterile tube. Excess moisture was 
removed from the swab by pressing it against the side of the tube during withdrawal. The 
moistened swab was then rolled 360 on the middle of the prepared site before being 
returned and sealed within the tube containing the preservation medium. The process was 
repeated for each site and the swabs were stored at 4C for up to 24 hours prior to 
laboratory testing. All sampling was conducted by a single operator. 
 
Microbiological Testing 
Each tube containing a microbiological swab was agitated for 30 seconds to distribute 
microbes throughout the preservation medium. A MacConkey agar plate (selective for 
Gram negative species) and a mannitol salt agar plate (selective for Gram positive 
species) were each spread evenly with 100µl of preservation medium and incubated 
aerobically at 37C for 18-24 hours before the plates were inspected. Colony-forming 
units (CFU) were counted manually by a single operator who was blinded to the skin 
preparation method used. 
 
Dermal Tolerance Scoring 
All sites were scored for clinical signs of a skin reaction (Table 1) by a single operator 
who was blinded to the skin preparation method used at each site: 
• Time A – immediately after clipping but before skin preparation. 
• Time B – immediately after skin preparation and microbiological sample collection. 
• Time C – 1 hour after skin preparation. 
• Time D – 24 hours after skin preparation. 
If any horse was deemed to require veterinary treatment for a skin reaction occurring as a 
result of skin preparation, then this was undertaken at the discretion of the qualified 
veterinary surgeons undertaking the skin preparation and dermal tolerance scoring. 
 
Data Analysis 
Data were analysed using SPSS Statistics for Windows version 23.0 (IBM Corp, 
Armonk, New York). Categorical data were analysed using cross-tabulation methods 
(Pearson Chi-Square and Fisher’s Exact). Numerical data were tested for normality 
(Shapiro-Wilk) and were not found to follow a Gaussian distribution; therefore these data 
were analysed using non-parametric tests (Mann-Whitney U and Kruskal-Wallis). 
Significance was set at P <0.05. For multiple, simultaneous analyses between groups, a 
Bonferroni correction was applied.   
RESULTS 
 
Twenty-five horses were recruited to the study and each horse was tested on both the left 
and right side, providing a total of 50 data sets. Thirteen geldings and 12 mares were 
included, ranging from 1 to 25 years of age (mean 9 years). There were 11 native breed 
ponies, 9 cobs, and 5 Thoroughbreds. Nine horses had a light coat colour, 8 were dark 
and 8 were multi-coloured. 
 
Microbiological Testing 
Site preparation method was correlated to the number of bacteria detected on both 
MacConkey (P <0.001) and mannitol salt (P <0.001) agar plates. The microbial burden 
was significantly reduced by all of the skin preparation methods using an antiseptic 
product when compared to the NC method, and there was no difference between 
antiseptics (Figures 2 and 3). 
 
The PC method (300 seconds) took longer than both the ABSA A (178.1 seconds; range 
140-220; P <0.001) and ABSA B (185.7 seconds; range 140-230; P <0.001) methods, but 
there was no difference between the ABSA A and ABSA B methods (P = 0.108).  
 
There was no significance of breed, coat colour, side of horse, or site number on the 
number of bacteria on either MacConkey or mannitol salt agar plates. 
 
Dermal Tolerance Scoring 
There was no correlation between site preparation method and dermal score at any time 
when considered overall, or when analysed between groups. 
 
97.5%, 83.5%, 82% and 69.5% of sites recorded a dermal tolerance score of ‘0’ at Time 
A, B, C and D respectively. The highest dermal tolerance score recorded was ‘2’ (Table 
1) at Time D only. The mean dermal tolerance score at each time was: 0.03 at Time A; 
0.16 at Time B; 0.18 at Time C; and 0.37 at Time D.  
 
Breed had a significant effect on dermal score at Time A (P = 0.038), although only one 
horse (a native breed pony) recorded all of the skin reactions at this time. At Time D, 
breed was also significant (P = 0.048) with Thoroughbreds demonstrating considerably 
more skin reactions (50.0%) than cobs (27.8%) or native breed ponies (23.9%). At Time 
B and Time C there was no difference between breed and dermal score. 
 
Coat colour was not a significant variable in relation to dermal score at any time.  
 
At Time C, 75% of skin reactions occurred on the right side of the horse (P = 0.001) but 
at all other times, there was no difference between the side of the horse and dermal score. 
 
Site number had a significant effect on dermal score at Times B (P = 0.028), C (P = 
0.001) and D (P <0.001) but not at Time A. Most skin reactions occurred at site number 1 
at Time B (45.5%), Time C (50.0%) and at Time D (44.3%).  
DISCUSSION 
 
The results of this study show that the alcohol-based skin antiseptic (ABSA) was as 
efficacious in reducing the microbial burden of equine skin as CHXG, requires 
significantly less time for patient skin preparation than a standard CHXG skin preparation 
method, and is well tolerated by horses. 
 
The ABSA tested in this study contains propan-2-ol which acts by coagulating proteins, 
causing them to denature. Its effect is mainly on the cell wall, cytoplasmic membrane and 
plasma proteins, causing a loss of cellular functions, increased permeability of the cell 
wall, and subsequent lysis of the organism.20 When combined with benzalkonium 
chloride, which disrupts intermolecular interactions leading to cell lysis as well,21 the 
overall action is bactericidal, yeasticidal, tuberculocidal and virucidal.19 
 
The ABSA was faster than CHXG with an average preparation time of approximately 3 
minutes (60 second scrub + 2 minute contact time) when compared to a standard 5 
minute CHXG skin preparation method. This reduction in skin preparation time is 
beneficial as it may contribute to a shorter overall anaesthetic time, which is pertinent in 
equine patients as perioperative mortality increases with anaesthetic duration.14 Another 
benefit is the reduced cost in terms of both staffing and materials to perform the skin 
preparation. We did not measure the exact volume of the ABSA used for each skin 
preparation in this study, which would have allowed a direct comparison of cost per unit 
area for each of the skin preparation methods used. However, the purchase price of the 
ABSA was less per millilitre when compared to the CHXG product used, and the overall 
volume used for the study was comparable for both products. Therefore, the cost of the 
ABSA seems comparable to that of CHXG which is commonly used in veterinary 
practice. It is possible that shorter scrub times using CHXG are achievable in equine 
patients, as in other species,1,13 but there are no studies documenting this finding to date. 
 
Both the ABSA and CHXG were well tolerated on equine skin which correlates well with 
studies using these products in other species. Dermal tolerance is commonly reported in 
human-based antiseptic studies,2,18,22 and occasionally reported subjectively in veterinary 
studies,1,3,7-8,10 but there are no objective reports for any products in equine patients. If the 
skin surrounding a surgery site becomes irritated, for instance from shaving to remove 
hair instead of clipping, bacteria may colonise the skin which increases the risk of an 
SSI.23 It is therefore pertinent to use an antiseptic that will minimise the risk of skin 
irritation surrounding the surgery site. The highest dermal score at any time point was a 
grade 2 out of 4 (Table 1) but no horses required any veterinary intervention to resolve 
their skin irritation.  
 
The effect of breed on dermal score at Time D only and that the side of horse was related 
to dermal score at Time C only is unclear in this sample set, especially given that these 
variables were not deemed significant at any other time point. A post-hoc analysis of 
power was not conducted as extrapolating from our data to predict what would happen if 
larger numbers were included would simply maintain these significant differences. The 
only way to determine whether our findings were true anomalies would be to repeat the 
study to establish whether fresh data showed lower variance. 
 
The skin preparation method used at each site was randomised but there was still an 
effect of site number on dermal score, with more skin reactions recorded at site number 1. 
This site was always the first to be clipped when starting skin preparation; dirt and/or hair 
were removed from the clippers with a clean stiff brush between horses and between each 
side of the same horse but no clipper lubricant was applied. A new clipper blade was 
applied if the current blade was deemed to be blunt and not cutting the hair adequately. 
We do not feel that the use of clean, sharp clippers, especially those without clipper 
lubricant applied, would be a contributing factor to the number of skin reactions seen at 
this site however other unidentified clipper-related factors may be responsible. 
Alternatively, this site was closest to the elbow and therefore it is hypothesised that the 
skin in this area is more sensitive than that closer to the flank; further studies are required 
to establish the dermal tolerance of both the ABSA and CHXG on other body areas in 
equine patients.  
 
In devising our study protocol, we chose to compare a standard 5 minute CHXG scrub, 
which is the method used in our equine hospital, to the selected ABSA (Cutasept F), a 
product designed to be used in the pre-operative preparation of human patients. Although 
the sustained action of CHXG may be reduced by rinsing with 70% isopropyl alcohol,8-9 
its use has become common in many hospitals and other studies1-3,5,7-9; as it was not 
within the aims of our study to report on the residual action of the antiseptics we 
therefore adopted this method of rinsing CHXG to maintain clinical applicability. 
 
The protocol for microbiological testing is similar to that used in other veterinary studies 
comparing the efficacy of antiseptic methods.5-6,10 However, unlike other studies,1,3-10 we 
chose not to conduct pre-antiseptic microbiological sampling, allowing determination of 
the percentage of CFU reduction as our aim was to compare the activity of four skin 
antiseptic methods, not to establish the final efficacy of the methods in preventing SSIs. 
The physical process of conducting pre-antiseptic microbiological sampling will 
inherently reduce the microbial burden of the skin, thereby giving a false result in terms 
of the overall number of CFUs and of the percentage of CFU reduction. Also, to the best 
of our knowledge, the number of CFUs required to initiate a SSI remains unknown and so 
calculation of the percentage of CFU reduction is unnecessary in this experimental study 
if we do not know what level of post-antiseptic CFUs is deemed acceptable. However, if 
the ABSA methods proved to be as effective at reducing skin microbial burden as CHXG 
at a single time point in this study, we could extrapolate that the ABSA would be safe 
enough to use in a clinical trial to establish its efficacy in reducing SSIs. 
 
We chose to examine the microbiological samples for common bacteria – Gram positive 
and Gram negative – to establish the basic effect of the skin preparation methods. In 
choosing to culture microbial growth on MacConkey (selective for Enterobacteriaceae 
species) and mannitol salt (selective for Staphylococcus species) agar plates, we accept 
that we would have not cultured the full complement of bacteria that may be involved in 
SSIs. However, as previously stated, it was not our aim to establish the efficacy of our 
skin preparation methods in preventing SSIs. A larger study would be necessary if 
examining for specific bacteria as these would not necessarily be as commonly present. 
Furthermore, an initial microbiological sample would have to be taken from each site to 
do this, which has problems as explained above. 
 
The limitations of this study include the small sample of horses used, and that it was 
conducted during summer months when all the horses were relatively clean and dry. It is 
known that the number of CFUs cultured from unclipped contaminated skin is higher 
than from unclipped clean skin10 and that clipping, as we did, can result in a higher 
number of pre-scrub CFUs compared to non-clipped skin.6 However there is no 
difference in the number of post-scrub CFUs when comparing clipped versus non-clipped 
skin6 and increased skin contamination is unlikely to affect the overall efficacy of the 
skin antiseptic.10 Our method of skin preparation required all swabs to be grossly clean 
after use and so the only potential effect of increased skin contamination is that the 
average scrub time in advance of applying an ABSA may become longer when used on 
horses during the winter months. Finally, we cannot rule out that the number of CFUs 
was reduced by continued antiseptic activity within the preservation medium or on the 
agar plates as we did not use antiseptic-neutralising medium or agar. However, it was 
assumed that this would be minimised by the dilution effect of the preservation medium 
and therefore would not negatively impact our results. 
 
We concluded that the alcohol-based skin antiseptic tested in this study is an efficacious, 
fast and well tolerated antiseptic for achieving skin antisepsis in horses. It now requires 
further validation to ensure it is safe and effective in clinical equine cases.  
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FIGURE LEGENDS 
 
Figure 1   Four clipped sites on the left side of a horse prior to skin preparation. 
 
Figure 2   Number of colony forming units (CFU) per swab against each skin preparation 
method – MacConkey agar. 
 
Figure 3   Number of colony forming units (CFU) per swab against skin preparation 
method – mannitol salt agar.  
TABLES 
 
Table 1   Dermal Tolerance Scoring. 
Score Description 
0 No clinical evidence of dermatitis 
1 Mild diffuse erythema and/or mild skin oedema 
2 
Moderate diffuse erythema and/or skin oedema with/without small vesicle 
formation 
3 
Severe diffuse erythema and/or skin oedema with/without large vesicle 
formation 
4 As for 3 but with signs extending beyond the treated area 
 
